Vistagen Therapeutics ‣ TradersQue

Thursday, July 16, 2026

Tags Vistagen Therapeutics

Fasedienol nasal spray bottle with pills, molecule model, and waveform

Vistagen Nears Critical CNS Milestone

Todd Analytics - November 11, 2025 0

VistaGen advances fasedienol’s Phase 3 PALISADE-3 toward data in late 2025, while PALISADE-4 continues enrollment, extending its CNS innovation momentum.

Unlock the ultimate trading experience with free membership, email notifications, and access to user profiles and forums. Join now for expert tips and in-depth market coverage! Elevate your trading game today!

The LAC-Panama Stalemate Continues

Commodities July 12, 2026

U.S. Manufacturing Growth Remains Elusive

Artificial Intelligence July 11, 2026

BYD’s Next Test Is Profit, Not Growth

Artificial Intelligence July 6, 2026

Tag: Vistagen Therapeutics

Vistagen Nears Critical CNS Milestone

Company

Popular posts

The LAC-Panama Stalemate Continues

U.S. Manufacturing Growth Remains Elusive

BYD’s Next Test Is Profit, Not Growth

Popular category